Prenatal HDAC inhibition by VPA transiently reduces the expression of Shank3 14 days after culturing embryonic neurons [263], which suggests the presence of a compensatory mechanism that reduces the genetic load for ASD, in contrast to the strong impact of  Shank3 mutations in Phelan-McDermid syndrome. Here, HDAC9 is linked to Phelan-McDermid syndrome.